[{"Assets_0_Q3_USD":9246552000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":233578000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":232487000.0,"StockholdersEquity_0_Q3_USD":-690317000.0,"RevenuesConverted_3_Q3_USD":2203777000.0,"RevenuesConverted_1_Q3_USD":772028000.0,"NetIncomeLossConverted_1_Q3_USD":-77207000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":232487000.0,"NetIncomeLossConverted_3_Q3_USD":-51183000.0,"EarningsPerShareDiluted_3_Q3_USD":-0.22,"EarningsPerShareDiluted_1_Q3_USD":-0.33,"EarningsPerShareBasic_3_Q3_USD":-0.22,"EarningsPerShareBasic_1_Q3_USD":-0.33,"CommonStockSharesOutstanding_0_Q3_shares":233668617.0,"CommonStockSharesConverted_0_Q3_shares":233668617.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":460914000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":233578000.0,"Ticker":"ENDP","CIK":"1593034","name":"ENDO INTERNATIONAL PLC","OfficialName":"Endo International plc Ordinary Shares","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"640358301.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211105"}]